Teladoc Health, Inc.
$1.40B- Market cap
- $1.14B
- Debt
- +$1.04B
- Cash
- −$781.08M
Capital structure 52% equity / 48% debt · EV / Revenue 0.55x · EV / EBITDA 4.74x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2024 ·
Decision snapshot: TDOC stock price vs PCH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PCH's multiple
Needs PCH P/S.
Implied fair value · at TDOC's multiple
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: TDOC FY 2025 (ended Dec 31, 2025) · PCH FY 2024 (ended Dec 31, 2024). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 52% equity / 48% debt · EV / Revenue 0.55x · EV / EBITDA 4.74x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TELADOC HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
POTLATCHDELTIC CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.75x
0.56x
Net debt / EBITDA
Leverage against operating earnings
0.87x
13.96x
Cash and equivalents
Liquid reserves on the balance sheet
$781.08M
$151.55M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Hims & Hers Health, Inc.
TDOC vs HIMS
GoodRx Holdings, Inc.
TDOC vs GDRX
Cigna Group
TDOC vs CI
VEEVA SYSTEMS INC
TDOC vs VEEV
WEYERHAEUSER CO
TDOC vs WY
RAYONIER INC
TDOC vs RYN
SIMMONS FIRST NATIONAL CORP
TDOC vs SFNC
ANNALY CAPITAL MANAGEMENT INC
TDOC vs NLY
AGNC Investment Corp.
TDOC vs AGNC
$1.04B
$1.13B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.